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Available online 19 March 2016AbstractThe heterodimeric mycobacterial receptors, macrophage C-type lectin (MCL) and macrophage inducible C-type lectin (Mincle), are upre-
gulated at the cell surface following microbial challenge, but the mechanisms underlying this response are unclear. Here we report that microbial
stimulation triggers Mincle expression through the myeloid differentiation primary response gene 88 (MyD88) pathway; a process that does not
require MCL. Conversely, we show that MCL is constitutively expressed but retained intracellularly until Mincle is induced, whereupon the
receptors form heterodimers which are translocated to the cell surface. Thus this “two-step” model for induction of these key receptors provides
new insights into the underlying mechanisms of anti-mycobacterial immunity.
© 2016 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Tuberculosis (TB), caused by Mycobacterium tuberculosis,
is one of the most prevalent infectious diseases with an esti-
mated two billion individuals infected worldwide [1]. Inter-
estingly, only a fraction of these carriers develop active
disease, a process that is not yet fully understood [2]. Human
genetic association studies have demonstrated an important
role for innate immune receptors and their signalling pathways
in TB susceptibility and disease progression [1]. Pattern
recognition receptors on innate immune cells play a crucial
role in both homoeostasis and host defence against pathogens.
Toll-like receptors and C-type lectin receptors (CTLRs) are* Corresponding author. Tel.: þ44 1224 437522.
** Corresponding author. Tel.: þ44 1224 437355; fax: þ44 1224 437348.
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http://dx.doi.org/10.1016/j.micinf.2016.03.007
1286-4579/© 2016 The Authors. Published by Elsevier Masson SAS on behalf of I
creativecommons.org/licenses/by/4.0/).the major families of surface expressed PRRs that detect
pathogen associated molecular patterns (PAMPs), triggering
complex signalling cascades to initiate host defences such as
the release of cytokines and chemokines, which are key for the
activation and recruitment of leukocytes during TB [1,3,4].
Toll-like receptors (TLRs) directly sense a variety of myco-
bacterial components such as glycolipids and glycoproteins
(TLR2/1), diacylated lipoproteins (TLR2/6), heat shock pro-
tein 60/65 (TLR4), and DNA motifs (TLR9) [1,5,6]. More
recently, several members of the Dectin-2 family of CTLRs
were shown to play a role in anti-mycobacterial immunity
through recognition of trehalose dimycolate (MCL, Mincle) or
mannose-capped lipoarabinomannan (Dectin-2) [7e10].
These receptors associate with the signalling adaptor FcRg for
surface expression and the transduction of an activating signal
[11]. Of particular importance here is MCL, which was shown
to play a non-redundant role in a murine pulmonary TB model
[10]. The current model for mycobacterial trehalosenstitut Pasteur. This is an open access article under the CC BY license (http://
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constitutive expression of MCL, which recognises the lipid
moiety of TDM [12]. This induces an activation signal,
transduced through the CARD9/Bcl10/MALT1 axis, leading
to NF-kB p65 initiation of Mincle expression [13,14].
Although MCL was described as a constitutively expressed
receptor and is highly expressed on resident peritoneal mac-
rophages, we and others have recently demonstrated that its
surface expression on myeloid cells can be significantly
upregulated by microbial stimuli in vitro and pulmonary
infection with Mycobacterium bovis Bacillus Calmette-Guerin
(BCG) in vivo [15,16]. MCL and Mincle were reported to form
functional heterodimers [15,16]. Notably, each receptor was
essential for surface expression of its heterodimeric partner
under naive conditions as well as during upregulation of
expression on BCG-infected bone marrow-derived macro-
phages (BMM) [15]. In this study, we investigated the mech-
anism underlying the induction of MCL and Mincle surface
expression following microbial stimulation.
2. Materials and methods2.1. Cells, bacterial strains, mice and reagentsC57BL/6 wildtype and matching Mincle/, MCL/ and
MyD88/ mice (on a C57BL/6 background) were housed
with access to water and food ad libitum in the specific
pathogen free animal facilities at the University of Aberdeen
(UK). Procedures were carried out in accordance with
approved protocols from the UK Home Office under project
licences 60/4007 and 70/8073. Bone marrow-derived macro-
phages (BMM) were generated in the presence of conditioned
L929 supernatant in complete RPMI medium (Gibco), as
described previously [17]. M. bovis BCG strain Pasteur was
grown on Middlebrook 7H10 agar or in Middlebrook 7H9
broth (BD) [10]. BMM were plated at 2.5  105 cells/well in
24 well plates (Thermo Scientific) for flow cytometry, or
1  106 cells/well in 6 well plates (Sigma) for total protein.
Stimulations with BCG (multiplicity of infection: 1), TLR-4
agonist LPS (100 ng ml1, Sigma) and TLR-2/1 agonist
Pam3CSK4 (100 ng ml
1, Invivogen) were carried out as
described previously [15,18].2.2. Flow cytometryFor analysis of receptor expression, cells were stained and
analysed by flow cytometry as described previously [15], in
the Iain Fraser Cytometry Centre at the University of Aber-
deen. Briefly, cells were harvested, passed through a 40 mm
cell strainer and red blood cells lysed in PharmLyse (BD),
before staining in FACS block (PBS, 0.5% BSA, 5% rabbit
serum, 5 mM EDTA, 1 mM azide) containing 4 mg/ml 2.4G2
Fc-receptor block. For intracellular staining, cells were fixed
in 1% paraformaldehyde in PBS, followed by permeabilisation
in 0.05% saponin (Sigma) in FACS Block. Antibodies used
were CD45 (clone 104), CD11b (clone M1/70), F4/80 (clone
Cl:A3-1), MCL-biotin (clone 3A4 [15]), Mincle-biotin (clone4A9 [7]) and Dectin-2-biotin (clone 11E4 [19]). Biotinylated
antibodies were detected with an appropriate streptavidin
conjugate (BD, Invitrogen) and measured by flow cytometry
on LSR Fortessa or Array instruments (BD) and data analysed
using FlowJo v.10.0.8. Mean fluorescent intensity (MFI) data
reported are MFI of anti-CTLR minus MFI of isotype control.2.3. Western blotCells were plated and stimulated as indicated in the figures
followed by lysis in ice cold RIPA buffer (50 mM Tris pH 8,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS, 1 mM EDTA) containing complete EDTA-free protease
inhibitor cocktail (Roche). Western blots on equal amounts of
protein quantitated by BCA assay (Pierce) were performed
following conventional protocols using the NuPAGE system
(Invitrogen) and probed with antibodies as indicated in the
figures. Equal loading was demonstrated by stripping the blots
(re-blot mild buffer, Millipore) and re-probing the membranes
with mouse anti-mGAPDH (clone mAbcam 9484).2.4. Data analysisData was compiled and analysed using FlowJo v10.0.8,
Excel and Graphpad Prism v5.04, and analysed with ANOVA
and Bonferroni post-test. Data was considered statistically
significant if p < 0.05.
3. Results3.1. Surface expression of MCL and Mincle is induced
by TLR ligandsWe recently reported that microbial challenge led to
increased expression of MCL and Mincle in an inter-
dependent fashion [15]. To confirm these findings, we stimu-
lated wild-type, Mincle/ and MCL/ BMM with LPS,
Pam3CSK4 or M. bovis BCG and assessed receptor surface
expression by flow cytometry. Consistent with our previous
observations, stimulation with microbial agonists strongly
increased surface expression of both MCL (Fig. 1A) and
Mincle (Fig. 1B) on wild-type cells [15]. Furthermore, the
induced surface expression of each of these CTLRs was
dependent on co-expression of its heterodimeric partner, since
expression of MCL or Mincle was substantially reduced on
Mincle/ (Fig. 1A) or MCL/ cells (Fig. 1B), respectively.
Notably, MCL expression was completely absent on Mincle/
 cells, but Mincle could still be induced on MCL/ cells,
albeit at low levels. This suggests that expression of Mincle is
not absolutely dependent on MCL, as we had previously
observed in alveolar macrophages [15].3.2. MCL is constitutively expressed but retained
intracellularlyWhile Mincle expression has been suggested to be
controlled by MCL on a transcriptional level, MCL is thought
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Fig. 1. Microbial stimuli promote translocation of Mincle and MCL to the cell
surface. BMM were treated for 16 h (h) with various microbial stimuli, as
indicated, and surface (AeC) and intracellular (D) protein expression assessed
for MCL or Mincle, by flow cytometry as indicated. MCL total cellular protein
was also analysed over time by Western blot analysis (E). Data shown from
individual experiments in duplicate and are representative of two independent
experiments. Data shown as mean þ standard deviation (SD). *, p < 0.05
compared to untreated control of the same strain. #, p < 0.05 compared to the
same treatment of the wild-type strain. e, unstimulated control.
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Fig. 2. MyD88 is required for MCL translocation the cell surface of BMM
following BCG challenge. BMM from various mouse strains, as indicated,
were stimulated with BCG for the specified number of hours and surface
expression of MCL (A) or Mincle (B) analysed by flow cytometry. (C) Total
protein levels of the receptors in BMM cell lysates, following BCG stimula-
tion, were analysed by Western blot. The data show mean þ SD of duplicates
and are representative of at least 2 independent experiments. *, p < 0.05
compared to wild-type.
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analysis of mRNA expression [7,13]. To gain further insight
into the underlying mechanism of induced surface expression,
we analysed the temporal dynamics of MCL and Mincle
protein expression in BMM following BCG stimulation by
flow cytometry. BCG was chosen for this analysis as it is a
physiologically relevant complex microbial ligand, compared
to a selected TLR agonist. Both receptors remained absent
from the cell surface for the first hour post stimulation and
demonstrated only a minor increase after 3 h before significant
surface expression was detected at 16 h post stimulation
(Fig. 1C). There was no change in receptor expression in the
absence of stimulation (data not shown). Surprisingly, we did
not observe surface expression of MCL preceding that of
Mincle following stimulation, at least at the time points ana-
lysed. Next, we investigated the possibility of an intracellular
pool of MCL, consistent with its reported constitutive mRNA
expression profile. Therefore we performed total protein
staining on fixed and permeabilised cells during a time course
experiment, as above. Indeed, we detected substantial amounts
of intracellular MCL protein in naïve BMM, with total protein
levels remaining largely unchanged following microbial
stimulation, as determined by flow cytometry (Fig. 1D). In
contrast, the expression of intracellular Mincle, mirrored thetime course of the surface expressed protein (Fig. 1D). The
presence of a total MCL protein pool over the entire time
frame of this analysis was confirmed by Western blot on whole
cell lysates, although there appeared to be a slight increase in
MCL levels at 16 h (Fig. 1E). Thus, MCL is a constitutively
expressed, but intracellularly retained receptor, whose surface
expression requires co-expression of Mincle, which is itself
only induced following an activation signal.3.3. MyD88 is essential for the induction of MCL surface
expression following microbial stimulationSince TLR agonists induce MCL and Mincle surface
expression (Fig. 1A and [15]), we hypothesised that TLR-
signalling may play a role in this process. Further support
for this hypothesis stems from published microarray data-
bases, where upregulation of MCL and Mincle during pul-
monary Chlamydia infection was shown to be MyD88-
dependent [20]. We therefore stimulated BMM from wild-
type, MCL/, Mincle/ and MyD88/ mice and ana-
lysed receptor surface expression by flow cytometry (Fig. 2A
and B). As we had observed previously, MCL expression
following BCG challenge increased over time in wild-type
mice, and required the presence of Mincle (Fig. 2A). In
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expression of these receptors by 6 h after stimulation.
Notably, loss of MyD88 led to substantial reductions in sur-
face expression of MCL, demonstrating the importance of
this TLR signalling pathway in this process. Similarly, the
surface expression of Mincle mirrored that of MCL and also
required MyD88 (Fig. 2B). Analysis of whole cell lysates,
revealed the presence of MCL in Mincle and MyD88-
deficient cells (Fig. 2C), consistent with a constitutive
expression profile [7]. In contrast, Mincle was induced
following stimulation and its levels increased over time, even
in the absence of MCL (Fig. 2C). However, this induction did
not occur in MyD88/ cells, revealing a critical role for this
signalling pathway in induction of Mincle and the subsequent
surface expression of both Mincle and MCL.S
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Fig. 3. MyD88 is dispensable for basal MCL/Mincle expression on resident
myeloid cells. (A) Example gating strategy for myeloid cells (here resident
peritoneal macrophages) for flow cytometric analysis of receptor expression on
cells from naïve mice. MCL and Mincle expression on (B) resident peritoneal
macrophages, (C) CD11bþF4/80þ monocytes in peripheral blood (PBL) and
(D) CD11bþ cells in bone marrow (BM). Data is representative of at least 3
mice from two independent experiments.MCL and Mincle are highly expressed on the surface of
naïve resident peritoneal macrophages and peripheral blood
leukocytes (PBL), in an interdependent manner [15]. Thus we
next explored whether MyD88 signalling is required for sur-
face expression of these CTLRs in naïve mice. Resident
peritoneal macrophages have the highest levels of surface re-
ceptor expression [15,21] and flow cytometric analysis of
CD11bþF4/80þ resident macrophages (Fig. 3A) confirmed
that high levels of MCL and Mincle are expressed at the
surface of these cells in an interdependent fashion (Fig. 3B).
Notably, surface expression of both receptors was not affected
by the absence of MyD88 (Fig. 3B). These findings were
supported by similar receptor expression profiles on PBL
(Fig. 3C) and bone marrow cells (Fig. 3D). Therefore, ca-
nonical TLR signalling through MyD88 is not required for
surface expression on the naïve myeloid cells examined here,
such as resident peritoneal macrophages.
4. Discussion
Our understanding of the role of members of the Dectin-2
family of C-type lectin receptors in anti-mycobacterial im-
munity has advanced significantly over the last few years.
Notably, Dectin-2, Mincle and MCL have all been shown to
recognise mycobacterial ligands with MCL, in particular,
demonstrated to play a key role in both mouse and human
[10]. Recently, MCL was reported by several groups,
including ours, to form a functional heterodimer with Mincle
[15,16,22]. Murine MCL co-immunoprecipitates with Mincle
and FcRg and the levels of MCL surface expression correlates
with those of Mincle in both primary and transduced cells
[15,16]. Consistent with previous reports [13,15], we show
here that following stimulation with microbial components the
high level of Mincle expression at the cell surface is dependent
on MCL, and vice versa. While MCL appears to increase
Mincle surface expression when overexpressed in vitro, MCL
has also been suggested to play a critical role in regulating
Mincle expression at a transcriptional level [13,16].Our data support a model of constitutive expression of
MCL and induction of Mincle following microbial stimula-
tion. However, we demonstrate that the induction of Mincle at
the protein level does not require MCL. Rather, we have found
that induction of Mincle following microbial stimulation re-
quires the MyD88 pathway, suggesting possible involvement
of TLR(s) in this process. Various TLRs have been implicated
in anti-mycobacterial immunity, but TLR2/4/9 triple-deficient
mice are able to control TB infection [23]. In contrast,
MyD88/ mice rapidly succumbed to the disease [24], a
phenotype linked to defects in IL-1 signalling [25]. Indeed,
preliminary analysis of TLR4 deficient BMM, revealed little
defect in surface expression of MCL or Mincle following BCG
stimulation (data not shown).
In conclusion, we propose that the MyD88 pathway, rather
than MCL signalling, is key for Mincle expression following
microbial challenge. Our data suggests a “two-step” model for
surface expression of MCL and Mincle following microbial
challenge in bone-marrow macrophages. In this model, mi-
crobial stimulation induces MyD88-mediated signalling
resulting in the upregulation of intracellular levels of Mincle
protein, that are detectible within 6 h of stimulation. Mincle
509B. Kerscher et al. / Microbes and Infection 18 (2016) 505e509then forms heterodimers with constitutively expressed MCL,
resulting in translocation of both CTLRs to the cell surface
where they mediate their anti-microbial activities. Our previ-
ous in vivo observations support this model: high level of
expression of these receptors was only induced in the lungs of
mice following mycobacterial infection [15]. Why such an
important innate recognition system [10] is not constitutively
expressed at high levels is still unclear. While clearly sufficient
to induce protective anti-mycobacterial responses [10], the low
levels of receptor expression in naïve animals may help pre-
vent unwanted inflammatory responses to the endogenous li-
gands that are also recognised by these CTLRs [11]. Future
work will be directed at understanding the underlying mech-
anisms of surface expression of Mincle/MCL in resident
macrophage populations in naïve animals, where MyD88 is
not required, and how these regulatory mechanisms are coor-
dinated in vivo during mycobacterial infection.
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